Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 18.28
+0.15 (0.83%)
Aug 10, 2026, 3:04 PM CST
SHE:000623 Market Cap
SHE:000623 has a market cap or net worth of 21.26 billion as of August 10, 2026. Its market cap has decreased by -5.33% in one year.
Market Cap
21.26B
Enterprise Value
20.83B
Revenue
2.23B
Ranking
n/a
PE Ratio
7.75
Stock Price
18.28
ChartMarket Cap Chart
Since April 11, 2006, SHE:000623's market cap has increased from 2.63B to 21.26B, an increase of 709.42%. That is a compound annual growth rate of 10.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 21.26B | -7.17% |
| Dec 31, 2025 | 22.90B | 10.86% |
| Dec 31, 2024 | 20.65B | 20.79% |
| Dec 29, 2023 | 17.10B | 0.46% |
| Dec 30, 2022 | 17.02B | -19.09% |
| Dec 31, 2021 | 21.03B | 10.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 24.87B |
| Guangdong Zhongsheng Pharmaceutical | 24.29B |
| Hubei Jumpcan Pharmaceutical | 23.86B |
| Tasly Pharmaceutical Group | 23.48B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.18B |
| Hybio Pharmaceutical | 21.53B |
| Walvax Biotechnology | 21.02B |
| Chengdu Kanghong Pharmaceutical Group | 20.96B |